CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


mouthrinse with bêta-cyclodextrin and citroxWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (3)


Name (Synonyms) Correlation
drug504 CVnCoV Vaccine Wiki 1.00
drug2902 mouthrinse without bêta-cyclodextrin and citrox Wiki 1.00
drug1822 Placebo Wiki 0.06

Correlated MeSH Terms (2)


Name (Synonyms) Correlation
D045169 Severe Acute Respiratory Syndrome NIH 0.05
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 COVID-19: Nasal and Salivary Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses: Double-blind, Randomized, Placebo-controlled Clinical Study

Given the current lack of effective COVID-19 treatment, it is necessary to explore alternative methods to contain the spread of the infection, focusing in particular on its mode of transmission. The modes of person-to-person transmission of SARS-CoV-2 are direct transmission, such as sneezing, coughing, transmission through inhalation of small droplets, and transmission through contact, such as contact with nasal, oral and eye mucous membranes. SARS-CoV-2 can also be transmitted directly or indirectly through saliva. The use of antiviral mouthrinses may be used as adjunctive therapy.

NCT04352959 COVID19 Mouthwash Saliva Device: mouthrinse with bêta-cyclodextrin and citrox Device: mouthrinse without bêta-cyclodextrin and citrox

Primary Outcomes

Description: Quantitative PCR experiments will be performed and a quantitative analysis of the salivary samples will be made

Measure: Change from Baseline amount of SARS-CoV-2 in salivary samples at 7 days

Time: 7 days

Secondary Outcomes

Description: Quantitative PCR experiments will be performed and a quantitative analysis of the nasal samples will be made

Measure: Change from Baseline amount of SARS-CoV-2 virus in nasal samples at 7 days

Time: 7 days


No related HPO nodes (Using clinical trials)